Advertisement
Screener

ABBOTT LABORATORIES (ABT) Patents: Active

ABBOTT LABORATORIES Active Patents

4,122 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2026-02-03: Application 30046198; Invention HIGH DENSITY CATHETER TIP; Applicant ST. JUDE MEDICAL, CARDIOLOGY DIVISION, INC.; Status Patented Case.
  • 2026-02-03: Application 30046188; Invention HIGH DENSITY CATHETER TIP; Applicant ST. JUDE MEDICAL, CARDIOLOGY DIVISION, INC.; Status Patented Case.
  • 2025-10-21: Application 30028989; Invention DISPLAY SCREEN OR PORTION THEREOF WITH TRANSITIONAL GRAPHICAL USER INTERFACE; Applicant Lingo Sensing Technology Unlimited Company; Status Patented Case.
  • 2025-09-25: Application 19340458; Invention ANALYTE SENSORS EMPLOYING MULTIPLE ENZYMES AND METHODS ASSOCIATED THEREWITH; Applicant Abbott Diabetes Care Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2026-02-0330046198HIGH DENSITY CATHETER TIPST. JUDE MEDICAL, CARDIOLOGY DIVISION, INC.Patented Case2026-06-30D1132442
Alan de la Rama
Cary Hata
Don Curtis Deno
Carlo Pappone
United States
United States
United States
Italy
MULLER, DAVID G
2026-02-0330046188HIGH DENSITY CATHETER TIPST. JUDE MEDICAL, CARDIOLOGY DIVISION, INC.Patented Case2026-07-28D1137659
Alan de la Rama
Cary Hata
Carlo Pappone
United States
United States
Italy
MULLER, DAVID G

Similar stocks

Stock NameCountryMarket CapPE Ratio
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64